Development of atherosclerosis and infectious agents

Internal Medicine

Volumn 42, Issue 7, 2003, Pages 547-548

  Yamamoto, Masahiro ^a  

^a Yokohama Stroke and Brain Center   (Japan)

Author keywords

Atherosclerosis; C reactive protein; Chlamydia pneumoniae; Cytomegalovirus; Helicobactor pylori; Herpesvirus; Infection; Ischemic stroke; Myocardial infarction

Indexed keywords

ANTIHYPERTENSIVE AGENT; C REACTIVE PROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMMUNOGLOBULIN G; TUMOR SUPPRESSOR PROTEIN;

ACUTE HEART INFARCTION; ANTIBODY TITER; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CHLAMYDOPHILA PNEUMONIAE; COMORBIDITY; CORONARY ARTERY ATHEROSCLEROSIS; CORRELATION ANALYSIS; CYTOMEGALOVIRUS; DEATH; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG EFFECT; EDITORIAL; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPOSURE; HELICOBACTER PYLORI; HEPATITIS A VIRUS; HERPES VIRUS; HUMAN; HYPERTENSION; INHIBITION KINETICS; JAPAN; NONHUMAN; PATHOGENESIS; PATHOGENICITY; PREDICTION; PROTEIN BINDING; RESPIRATORY TRACT INFECTION; RISK ASSESSMENT; STROKE; SURVIVAL; TOOTH INFECTION; TREATMENT OUTCOME; URINARY TRACT INFECTION;

EID: 0041670949     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.42.547     Document Type: Editorial

References (26)

1. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med 340: 115-126, 1999.
2. Kiechl S, Egger G, Mayr M, et al. Chronic infections and the risk of carotid atherosclerosis: Prospective studies result from a large population study. Circulation 103: 1064-1070, 2001.
3. de Beer FC, Hind CR, Fox KM, Allen RM, Maseri A, Pepys MB. Measurement of serum C-reactive protein concentration in myocardial ischemia and infarction. Br Heart J 47: 239-243, 1982.
4. Koenig W, Sund M, Frohlich M, et al. C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA Augsburg Cohort Study, 1984-1992. Circulation 99: 237-242, 1999.
5. Muhlestein JB, Anderson JL. Infectious serology and atherosclerosis. Circulation 107: 220-222, 2003.
6. Epstein SE, Zhou YF, Zhu J. Infection and atherosclerosis: emerging mechanistic paradigms. Circulation 100: e20-e28, 1999.
7. Muhlestein JB, Anderson JL, Hammond EH, et al. Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model. Circulation 97: 633-636, 1998.
8. Muhlestein JB, Hammond EH, Carlquist JF, et al. Increased incidence of Chlamydia species within the coronary arteries of patients with symptomatic atherosclerotic versus other forms of cardiovascular disease. J AM Coll Cardiol 27: 1555-1561, 1996.
9. Porqueddu M, Spirito R, Parolari A, et al. Lack of association between serum immunoreactivity and Chlamydia pneumoniae detection in the human aortic wall. Circulation 106: 2647-2648, 2002.
10. Prasad A, Zhu J, Halcox JPJ, et al. Predisposition to atherosclerosis by infections: role of endothelial dysfunction. Circulation 106: 184-190, 2002.
11. Danesh J, Whincup P, Walker M, Waclawiw MA, Epstein SE, Quyyumi AA. Chlamydia pneumoniae IgG titers and coronary heart disease: prospective study and meta-analysis. BMJ 321: 208-213, 2000.
12. Danesh J. Coronary heart disease, Helicobactor pylori, dental disease, Chlamydia pneumoniae, and cytomegarovirus: meta-analyses of prospective studies. Am Heart J 138: S434-S437, 1999.
13. Anderson JL, Carlquist JF, Muhlestein JB, Horne BD, Elmer SP. Evaluation of C-reactive protein, an inflammatory marker, and infectious serology as risk factors for coronary artery disease and myocardial infarction. J Am Coll Cardiol 32: 35-41, 1998.
14. Muhlestein JB, Horne BD, Carlquist JF, et al. Cytomegarovirus seropositivity and C-reactive protein have independent and combined predictive value for mortality in patients with angiographically demonstrated coronary artery disease. Circulation 102: 1817-1923, 2000.
15. Rupprecht HJ, Blankenberg S, Bickel C, et al. Impact of viral and bacterial infectious burden on long-term prognosis in patients with coronary artery disease. Circulation 104: 25-31, 2001.
16. Smieja M, Gnarpe J, Lonn E, et al. Multiple infections and subsequent cardiovascular events in the heart outcome prevention evaluation (HOPE) study. Circulation 107: 251-257, 2003.
17. Horne BD, Muhlestein JB, Carlquist JF, et al. Statin theraphy interacts with cytomegalovirus seropositivity and high C-reactive protein in reducing mortality among patients with angiographically significant coronary disease. Circulation. 107: 258-263, 2003.
18. Virok D, Kis Z, Karai L, et al. Chlamydia pneumoniae in atherosclerotic middle cerebral artery. Stroke 32: 1973-1976, 2001.
19. Wimmer ML, Sandmann-Strupp R, Saikku P, Haberl RL. Association of chlamydial infection with cerebrovascular disease. Stroke 27: 2207-2210, 1996.
20. Elkind MS, Lin IF, Grayston JT, Sacco RL. Chlamydia pneumoniae and the risk of first ischemic stroke: The Northern Manhattan Stroke Study. Stroke 31: 1521-1525, 2000.
21. Glader CA, Sregmayr B, Boman J, et al. Chlamydia pneumoniae antibodies and high lipoprotein(a) levels do not predict ischemic cerebral infarctions. Results from a nested case-control study in Northern Sweden. Stroke 30: 2013-2018, 1999.
22. Heuschmann PU, Neureiter D, Gesslein M, et al. Association between infection with Helicobactor pylori and Chlamydia pneumoniae and risk of ischemic stroke subtypes: Results from a population-based case-control study. Stroke 32: 2253-2258, 2001.
23. Gerdes VE, Verkooyen RP, Kwa VI, et al. Chlamydial LPS antibodies, intima-media thickness and ischemic events in patients with established atherosclerosis. Atherosclerosis 167: 65-71, 2003.
24. Kawamoto R, Kajiwara T, Oka Y, Takagi Y. An association between an antibody against Chlamydia pneumoniae and ischemic stroke in elderly Japanese. Intern Med 42: 571-575, 2003.
25. Fagerberg B, Gnarpe J, Gnarpe H, Agewall S, Wikstrand J. Chlamydia pneumoniae but not cytomegalovirus antibodies are associated with future risk of stroke and cardiovascular disease: a prospective study in middle-aged to elderly men with treated hypertension. Stroke 30: 299-305, 1999.
26. Tarnacka B, Gromadzka G, Czlonkowska A. Increased circulating immune complexes in acute stroke: the triggering role of Chlamydia pneumoniae and cytomegalovirus. Stroke 33: 936-940, 2002.